Drug Trial Radar · NCT07631637
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Jul 6, 2026
Primary completion
Jan 29, 2029
Study completion Jan 29, 2029
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Jun 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease called MASH. In this study, researchers are looking at the effect of ALN-CIDEB on reducing liver fat, liver injury, and liver scarring. The study will compare ALN-CIDEB with placebo to understand how well ALN-CIDEB works to lower the amount of fat in the liver. The study is looking at: * What side effects ALN-CIDEB might cause * How well ALN-CIDEB works to change liver fat, liver injury, and liver scarring * How the body and the liver change after having ALN-CIDEB, which can help researchers understand why ALN-CIDEB works better for some people than others
Conditions
- Metabolic Dysfunction-Associated Steatohepatitis
- MASH
Interventions
ALN-CIDEBDrug
Administered per the protocol
PlaceboDrug
Administered per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in Liver Fat by Magnetic Resonance Imaging-derived Proton Density Fat Fraction (MRI-PDFF)Time frame: At week 52
Locations
24 sites in 3 countries. Site status is shown where the registry gives one.
Adobe Clinical Research
Tucson, Arizona · Recruiting
The Institute for Liver Health II LLC dba Arizona Liver Health
Tucson, Arizona · Recruiting
Del Sol Research Management, LLC
Tucson, Arizona · Recruiting
California Liver Research Institute
Pasadena, California · Recruiting
Inland Empire Clinical Trials
Rialto, California · Recruiting
Universal Axon Clinical Research
Doral, Florida · Recruiting
Southwest General Healthcare Center
Fort Myers, Florida · Recruiting
Genoma Research Group, Inc.
Miami, Florida · Recruiting
Med Research of Florida, LLC
Miami, Florida · Recruiting
Indiana University School of Medicine
Indianapolis, Indiana · Recruiting
Kansas Medical Clinic
Topeka, Kansas · Recruiting
Tandem Clinical Research
Marrero, Louisiana · Recruiting
Tandem Clinical Research
Metairie, Louisiana · Recruiting
Geisinger Medical Center
Danville, Pennsylvania · Recruiting
Quality Medical Research - Nashville
Nashville, Tennessee · Recruiting
Texas Clinical Research Institute, LLC
Arlington, Texas · Recruiting
American Research Corporation
Austin, Texas · Recruiting
Methodist Dallas Medical Center
Dallas, Texas · Recruiting
Advanced Medical Trials
Georgetown, Texas · Recruiting
Pioneer Research Solutions, Inc.
Houston, Texas · Recruiting
American Research Corporation at The Texas Liver Institute
San Antonio, Texas · Recruiting
Siena Research Network
Sugar Land, Texas · Recruiting
Fundacion de Investigacion (FDI) Clinical Research
San Juan, Puerto Rico · Recruiting
The Newcastle upon Tyne Hospitals NHS Trust
Newcastle upon Tyne, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.